Member access

4-Traders Homepage  >  Shares  >  Nyse  >  Pfizer Inc.    PFE   US7170811035

PFIZER INC. (PFE)

279
Delayed Quote. Delayed Nyse - 04/15 04:02:29 pm
29.89 USD   +0.07%
5h ago PFIZER : Acura Pharmaceuticals Reports Return of Product Rights
5h ago PFIZER : IntegraGen Enters Collaborative Pact with Pfizer
1d ago PFIZER : Rolls Out PALOMA-1 Study Results
SummaryQuotesChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Latest news on PFIZER INC.
5h ago PFIZER : Acura Pharmaceuticals Reports Return of Product Rights
5h ago PFIZER : IntegraGen Enters Collaborative Pact with Pfizer
1d ago PFIZER : Rolls Out PALOMA-1 Study Results
2d ago PFIZER : Advil® Relief in Action and Josh Duhamel Celebrate National Volunteer W..
3d ago PFIZER : IntegraGen Updates on Collaborative Pact with Pfizer
6d agoDJACURA PHARMACEUTICALS : Ends Licensing Pact With Pfizer
6d ago PFIZER : AMCP Foundation Launches Initiative to Identify Emerging Medication Man..
6d ago PFIZER : PSE & Pfizer form the Systems-based Pharmaceutics Alliance
6d ago INTEGRAGEN : Announces Collaborative Agreement with Pfizer to Evaluate IntegraGe..
6d ago PFIZER : Patent Issued for Process for Forming Amorphous Atorvastatin
6d ago PFIZER : LabCentral Announces Sponsorship by Pfizer to Support Life-Science Star..
6d ago MERCK KGAA : EMD Serono Enters into Research Agreement with Pfizer and Broad Ins..
7d ago PFIZER : Innovative Blue Button Project to Be Discussed at DIA 2014 50th Annual ..
04/09 PFIZER : Releases PALOMA-1 Study Results
04/08 UNTAXED U.S. CORPORATE PROFITS HELD : study
04/08 PFIZER : IntegraGen Reports Collaborative Agreement with Pfizer
04/08 PFIZER : IntegraGen Enters Collaborative Agreement with Pfizer
04/07DJMARKET SNAPSHOT : U.S. Stocks Fall; Nasdaq 3-day Loss Worst Since 2011
04/07 PFIZER : Novel CDK 4/6 Inhibitor Palbociclib plus Letrozole Significantly Prolon..
04/07DJMARKET SNAPSHOT : U.S. Stocks Fall; Nasdaq 3-day Loss Worst Since 2011
04/06 PFIZER : Novel CDK 4/6 Inhibitor Palbociclib plus Letrozole Significantly Prolon..
04/04 Exclusive - Merck wants to test Zilmax on 240,000 cattle but beef industry re..
04/03 Apple, Pfizer, others form 'go slow' U.S. patent lobby group
04/03 PFIZER : $1.12 Billion Federal Contract Awarded to Pfizer
04/02 PFIZER : Achieves Primary Endpoint With Phase 3B Top-Line Results Of GENOTROPIN®..
04/02 BRISTOL MYERS SQUIBB : In A Subanalysis, The Benefits Of Eliquis® apixaban Vs. W..
04/02 PFIZER : Reports Positive Phase 3 Study Outcome Of XALKORI® crizotinib Compared ..
04/02 PFIZER : Bococizumab RN316 Significantly Reduced LDL Cholesterol In Statin-Treat..
04/01 PFIZER : ViiV Healthcare announces new initiatives to improve access to dolutegr..
03/31DJBAYER : Gets EU Approval for Adempas to Treat Lung Disease
03/30 PFIZER : Presents Positive Phase 3 Study Findings of XALKORI (crizotinib) Compar..
03/30DJNEW DRUGS TO LOWER CHOLESTEROL SHOW : Studies
03/28 PFIZER : Statement on U.S. FDA Approval of Over-the-Counter Nexium® 24HR
03/28 Patent tribunal breather to pfizer
03/27DJU.S. HOT STOCKS : Hot Stocks to Watch
03/27DJPFIZER : Experimental Anti-cholesterol Treatment Meets Main Study Goals
03/27 PFIZER : Achieves Primary Endpoint With Phase 3B Top-Line Results Of GENOTROPIN ..
03/27 PFIZER : Bococizumab (RN316) Significantly Reduced LDL Cholesterol In Statin-Tre..
03/26 BRISTOL MYERS SQUIBB : Updates on FDA Approval of Eliquis (apixaban)
03/26 PFIZER : Reports Results of OPT Compare
03/26 BRISTOL MYERS SQUIBB : U.S. FDA Approves Eliquis® apixaban To Reduce The Risk Of..
03/26 Most active New York Stock Exchange-traded stocks
03/26 PFIZER : Investigational Vaccine Candidate Bivalent rLP2086 Receives U.S. Food a..
03/26DJPFIZER : Genotropin Shows Positive Results in Study
03/26 PFIZER : Achieves Primary Endpoint With Phase 3B Top-Line Results Of GENOTROPIN®..
03/26 PFIZER : Reports Positive Phase 3 Study Outcome Of XALKORI (crizotinib) Compared..
03/25 PFIZER : Invites Public To View And Listen To Webcast Of May 5 Conference Call W..
03/25 PFIZER : Implantation or Injectable Dosage Form New Animal Drugs; Change of Spon..
03/25DJU.S. HOT STOCKS : Hot Stocks to Watch
03/25 PFIZER : A.M. Best Affirms Ratings of Blue Whale Re Ltd
03/25 PFIZER : Reports Positive Phase 3 Study Outcome Of XALKORI® (crizotinib) Compare..
03/24 PFIZER INC. : Renaissance Technologies Buys Stake in Pfizer; Yahoo Looks to Prof..
03/24 Most active New York Stock Exchange-traded stocks
03/24 NYSE ACTIVE RUNNERS : Bank of America Corp (NYSE:BAC), Pfizer (NYSE:PFE) , Gener..
03/24 PFIZER : Sues torrent over viagra generic
03/22 PFIZER : to Webcast Conference Call with Securities Analysts to Review Palbocicl..
03/22 PFIZER : Announces Detailed Results of OPT Compare Phase 3 Study of Tofacitinib ..
03/21DJProposed Law Would Require More Drug-Trial Transparency
03/21 Most active New York Stock Exchange-traded stocks
03/20 PFIZER : Investigational Vaccine Candidate Bivalent rLP2086 Receives U.S. Food a..
03/19 PFIZER : Will Appeal Court Decision Regarding Celebrex Reissue Patent
03/19 BRISTOL MYERS SQUIBB : U.S. FDA Passes Eliquis (apixaban) as a Drug to Reduce th..
03/18 PFIZER : Launches 2013 Integrated Annual Review
03/17 Most active New York Stock Exchange-traded stocks
03/16 PFIZER : to Webcast Conference Call with Securities Analysts to Review Palbocicl..
03/16 PFIZER : Presents Results from Landmark Community-Acquired Pneumonia Immunizatio..
03/14 Most active New York Stock Exchange-traded stocks
03/13DJMARKET SNAPSHOT : U.S. Stocks Slide; Dow Sees Triple-digit Loss
03/13DJMARKET SNAPSHOT : U.S. Stocks Fall; Dow Drops Over 100 Points
03/13DJU.S. HOT STOCKS : Hot Stocks to Watch
03/13DJMylan Plans to Start Selling Generic Celebrex in May
03/12 STERICYCLE : Pfizer Initiates Nationwide Voluntary Recall of Two Lots of Pfizer'..
03/12 PFIZER INC. : Pfizer Will Appeal Court Decision Regarding Celebrex Reissue Paten..
03/12 PFIZER : Study pinpoints protective mutations for type 2 diabetes
03/12 Most active New York Stock Exchange-traded stocks
1  2  3  4  5  6  7  8  9  10Next
Advertisement
Chart
Duration : Period :
Pfizer Inc. Technical Analysis Chart | PFE | US7170811035 | 4-Traders
Income Statement Evolution
Pfizer Inc. : Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF